Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia
about
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsSenescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth.
P2860
Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Stromal response to prostate c ...... f benign prostatic hyperplasia
@ast
Stromal response to prostate c ...... f benign prostatic hyperplasia
@en
Stromal response to prostate c ...... f benign prostatic hyperplasia
@nl
type
label
Stromal response to prostate c ...... f benign prostatic hyperplasia
@ast
Stromal response to prostate c ...... f benign prostatic hyperplasia
@en
Stromal response to prostate c ...... f benign prostatic hyperplasia
@nl
prefLabel
Stromal response to prostate c ...... f benign prostatic hyperplasia
@ast
Stromal response to prostate c ...... f benign prostatic hyperplasia
@en
Stromal response to prostate c ...... f benign prostatic hyperplasia
@nl
P2093
P2860
P1433
P1476
Stromal response to prostate c ...... f benign prostatic hyperplasia
@en
P2093
Elizabeth Singer
Gail Babilonia
Jennifer Linehan
S Ashraf Imam
Sofia Loera
Steven Smith
Timothy Wilson
P2860
P304
P356
10.1371/JOURNAL.PONE.0060562
P407
P577
2013-01-01T00:00:00Z